Shore Comprehensive Urology is devoted to clinical excellence in urology care. We are available for support throughout each step of the process from diagnosing urology disorders to performing urology treatments and procedures. Our multidisciplinary urological team of physicians, nurses and support staff is dedicated to work for the best interest of our urology patients.

Robotic-Assisted Surgery. Watch Dr. Runz talk about da Vinci® robotic surgery for prostatectomy.

Shore Comprehensive Urology is located at 505 Dutchman's Lane, Bldg A, in Easton, at 2 Aurora Street in Cambridge and 6602 Church Hill Road, Suite 550 in Chestertown.

Urological Services

For more information on our services please visit shorecomprehensiveurology.com
Bladder Cancer
BPH (Benign Prostatic Hyperplasia)
da Vinci Robotic Surgery
Expert Anatomical and Molecular Pathology Consultations*
Female Urology
Genito-Urinary Trauma
Impotence
Incontinence
Interstitial Cystitis
Kidney Cancer
Laparoscopic Kidney, Adrenal, and Bladder Surgery
Male Infertility
Minimally Invasive Surgery

Pediatric Urology
Peyronie's Disease
Prostate Cancer
Prostatitis
Stone Disease
Urinary Tract Infections (UTI)
Vasectomy
Vasectomy Reversals
Female Urology
Pediatric Urology
Male Reconstructive Surgery

Patient Education

Frequently Asked Questions (FAQ) About the Robotic Prostate Surgical Procedure
Radio Interview - Cryoablation
Dr. Foley discusses prostate cancer and cryoablation on the radio show Ask Dr. Barken.
Us TOO Prostate Cancer Support Group Meetings:
For information about the Us TOO Prostate Cancer Support Group, click here
PSA Tracker
Track your PSA levels on your computer with this tool from prostate.com

Clinical Trials

Shore Comprehensive Urology Associates is actively participating in clinical trials for cancer treatment and prevention through Shore Regional Cancer Center.
A clinical trial is a study designed to evaluate the potential benefit of new treatments. The goal is to find better ways to prevent, detect, or treat cancer or to improve care for people with cancer.
Currently, less than 10% of adult cancer patients enroll in trials. The main reason for this is a lack of awareness of clinical trials. Most, if not all, major advancements in the treatment of cancer have come as a direct result of patient participation in clinical trials.
We are participating in the following clinical trials:
SWOG 9346: This study is looking at intermittent versus continuous hormone therapy for patients with prostate cancer.
CALGB 90202: This study will test whether early treatment with a medication (zoledronic acid) will reduce the risk of bone pain and fracture in prostate cancer patients.

Go home